Sclerostin, the osteocyte-expressed and secreted inhibitor of bone formation, can also be found at higher levels in the crevicular fluid from periodontitis patients and could be a more reliable measure for diagnosis or prognosis of disease than RANKL [41]. This evidence concerns the gene SOST and periodontitis.